KPI Sets for ECs and Periodic Review


Published on 28/11/2025

KPI Sets for Effectiveness Checks and Periodic Review

Introduction to Change Control Impact Assessment

The pharmaceutical industry operates in a highly regulated environment where change control is a critical function. This process ensures that all changes, whether in processes, equipment, or quality systems, are systematically evaluated and controlled. One essential aspect of change control is the change control impact assessment, which evaluates potential risks and the necessity for verification or re-validation of affected systems. This article serves as a step-by-step guide for pharma professionals to navigate the complexities of change control, focusing on effectiveness checks and periodic reviews.

Understanding Verification vs Re-Validation

At the core of any change control process is the decision-making surrounding verification versus re-validation. This distinction is critical for compliance with both 21 CFR Part 211 and European regulations that govern Good Manufacturing Practice (GMP). Verification involves assessing whether the system still performs as intended under its current configuration without the need for substantial re-testing. In contrast, re-validation typically indicates that significant alterations have occurred, necessitating a comprehensive review and testing of the system.

Step 1: Identifying Changes that Require Assessment

  • Analyze the proposed change against established risk-based change thresholds to determine the level of assessment required.
  • Document all changes that could affect product quality, efficacy, or safety, per regulatory standards.
  • Use historical data as a benchmark to identify patterns that indicate the necessity for deep assessments.

Step 2: Conducting a Preliminary Change Control Impact Assessment

The preliminary assessment should evaluate potential impacts on product quality and regulatory compliance. Key factors include:

  • The nature of the change: Is it minor (e.g., a change in supplier) or major (e.g., new manufacturing equipment)?
  • Implications for existing risk assessments: Are the identified risks still valid, or do they require updates?
  • The presence of bridging studies that may provide data on the effects of the change on product quality.

Step 3: Developing and Implementing Sampling Plan Updates

If the preliminary assessment indicates potential impacts, updating the sampling plan may be necessary. This process involves extending the monitoring of key metrics to track the implications of changes. Evidence packs should be compiled for all new data generated during this phase.

  • Ensure sampling plans cover appropriate statistical representations of the affected batches.
  • Define acceptance criteria based on risk assessments and historical data trends.
  • Document all modifications in the Quality Management System (QMS) to allow traceability.

KPI Development for Periodic Reviews

Implementing Key Performance Indicators (KPIs) for effectiveness checks is imperative for ensuring ongoing compliance and process reliability. KPIs serve as metrics that facilitate a structured evaluation of the change control process.

Step 4: Establishing Relevant KPIs

The selection of KPIs should align with business objectives and regulatory compliance requirements. Key considerations include:

  • Quality metrics: These can include defect rates, batch rejection rates, and out-of-specification (OOS) results.
  • Operational metrics: These involve process efficiency, including throughput rates and downtime caused by changes.
  • Compliance metrics: Focus on the frequency of deviations and non-conformances related to changes.

Step 5: Conducting Periodic Review of Effectiveness Checks

Periodic reviews should be conducted to assess the effectiveness of the implemented changes. This is where the periodic review process converges with effectiveness checks. Regulatory frameworks such as Annex 15 require that these reviews be performed systematically.

  • Schedule reviews at predefined intervals based on product risk levels and historical performance.
  • Engage cross-functional teams to review KPI results, ensuring diverse inputs and thorough analysis.
  • Utilize evidence packs to substantiate findings and decisions during review meetings.

Step 6: Adjusting CPV Limits as Necessary

Continuously adjusting CPV (Continued Process Verification) limits based on the aggregated findings from periodic reviews is essential for proactive quality assurance. High CPV limits may indicate process stability, while frequently breached limits could necessitate further investigation or changes in operational procedures.

Documenting and Communicating Findings

Clear documentation and communication are vital components of effective change control management. By articulating findings in a structured manner, organizations ensure compliance and facilitate informed decision-making.

Step 7: Documenting All Assessments and Reviews

  • All assessments should be documented in a centralized location that is accessible to relevant stakeholders.
  • Communicate findings to all affected departments, ensuring the relevance and importance of the changes are understood company-wide.
  • Maintain a clear audit trail of all decisions made in the change control process.

Step 8: Training and Continuous Improvement

It is critical to train staff on the change control process, including the significance of effectiveness checks and the implications of compliance with guidelines from bodies like the WHO. Continuous training ensures that personnel are well-versed in current policies and practices, ultimately leading to a culture of quality within the organization.

  • Conduct regular training sessions to update staff on changes in regulatory requirements.
  • Incorporate feedback mechanisms to enhance the training program continually.
  • Align training content with identified gaps from periodic reviews.

Conclusion

Effective change control, centered around a rigorous impact assessment, verification versus re-validation, and robust periodic reviews, is essential in maintaining product quality and regulatory compliance in the pharmaceutical industry. Employing risk-based approaches ensures that organizations remain agile and prepared to adapt to changes while safeguarding the interests of patients and stakeholders alike. By following the structured steps outlined in this guide, pharmaceutical professionals can enhance their understanding of key processes and contribute to a culture of continuous improvement.